USPTO trademark

GARZULYS

Under examinationUSPTOWord and designClass 5

"GARZULYS" is a word and design mark owned by Emerge Bioscience Pte. Ltd., filed at the USPTO on February 26, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Emerge Bioscience Pte. Ltd. portfolioGet this data via the API
Official USPTO record
GARZULYS trademark as filed
As filed with the USPTO
Status
Under examination
Since June 25, 2026
Filed
February 26, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99672171
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns GARZULYS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Emerge Bioscience Pte. Ltd.

Singapore, Singapore

9 trademarks in the portfolioView company

Representative

Eric R. Moran

McDonnell Boehnen Hulbert & Berghoff LLP

Goods and services

What the mark covers

The products and services GARZULYS is filed for, grouped by Nice class.

  • Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin aspart; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin aspart; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin aspart; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application extension granted/receipt provided
  2. Application extension to response period - received
  3. Notification of non-final action e-mailed
  4. Non-final action e-mailed
  5. Non-final action written
  6. Assigned to examiner
  7. Notice of design search code e-mailed
  8. New application office supplied data entered
  9. Application filing receipt mailed
  10. New application entered
FAQ

About GARZULYS

Who owns the trademark "GARZULYS"?

The USPTO trademark "GARZULYS" (application 99672171) is owned by Emerge Bioscience Pte. Ltd.

What is the status of "GARZULYS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GARZULYS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bae-fb9d-72ac-a427-306dd1dbd7b1
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bae-fb9d-72ac-a427-306dd1dbd7b1",
  "object": "trademark",
  "mark_text": "GARZULYS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99672171",
  "filing_date": "2026-02-26",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Emerge Bioscience Pte. Ltd.",
      "entity_id": "ent_019eb720-2d4e-7566-b909-d1f8d0376b1d"
    }
  ]
}